Leal Therapeutics is a biotechnology company developing treatments for central nervous system disorders, focusing on amyotrophic lateral sclerosis (ALS) and schizophrenia.

Nura Bio Inc. develops neuroprotective therapies for neurological diseases, with a focus on advancing their lead candidate, a brain-penetrant SARM1 inhibitor.

Circle Pharma is a biopharmaceutical company developing cell-permeable macrocycle treatments for cancer and other serious diseases.

Actio Biosciences is a biotechnology company that uses its proprietary platform for genetics and precision medicine to develop therapeutics for both rare and common diseases, with a focus on TRPV4 mutations for the treatment of Charcot-Marie-Tooth disease type 2C and other serious bone diseases.